| 25.19 Data as of Jun 19 |  -0.01 / -0.04%Today’s Change | 16.75 Today|||52-Week Range 28.60 | +28.06% Year-to-Date |
| SECTOR Consumer Non-Durables | INDUSTRY Household/Personal Care | MARKET CAP $115.8M |
Company Description
United-Guardian, Inc. develops and manufactures pharmaceuticals, cosmetic ingredients, personal and health care products and medical devices. The company also conducts research and development, primarily related to the development of new and unique cosmetic and personal care products. Its products are separated into four distinct product categories: pharmaceuticals, personal and health care, medical and industrial products. Its products are sold under the trademarks owned by the company, which include LUBRAJEL and RENACIDIN. The company also sells a small quantity of pharmaceutical products directly to hospitals and pharmacies. The non-pharmaceutical medical products and the specialty industrial products are sold directly by the company to the end users or to contract manufacturers utilized by the end users. United-Guardian was founded in 1942 and is headquartered in Hauppauge, NY.
Employees
Shareholders
| Mutual fund holders | 9.49% |
| Individual stakeholders | 57.28% |
| Other institutional | 5.63% |
Top Executives
| Kenneth H. Globus | Chairman, President & General Counsel |
| Robert S. Rubinger | CFO, Secretary, Treasurer, Director & Executive VP |
| Joseph J. Vernice | Vice President & Director-Technical Services |
| Charles W. Castanza | Senior Vice President & Director-Plant Operations |
| Peter A. Hiltunen | Vice President & Production Manager |
.
